DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma
about
Diffusion-weighted MRI as a biomarker for treatment response in gliomaProfilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.Early detection of Lewis lung carcinoma tumor control by irradiation using diffusion-weighted and dynamic contrast-enhanced MRI.Differentiating laryngeal carcinomas from precursor lesions by diffusion-weighted magnetic resonance imaging at 3.0 T: a preliminary study.Molecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinomaGemcitabine Plus Radiation Therapy for High-Grade Glioma: Long-Term Results of a Phase 1 Dose-Escalation Study.DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases.Diffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map AnalysisInhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedulesFunctional imaging for radiotherapy treatment planning: current status and future directions-a review.Biological imaging in clinical oncology: radiation therapy based on functional imaging.BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells.
P2860
Q30660991-82DE8D18-26D0-4050-B048-DFDDD1433F6FQ33675114-18575D67-05C1-4120-8926-17CA1717C13EQ34712745-8D331005-A51E-4B89-9596-A8B2D758B1CAQ34849836-B063F872-C1B5-4DE6-96B2-836ED7C8F462Q36511080-F9C98024-4C5C-407F-B65D-939534385F15Q36559617-41A988CC-B656-44D7-A2E0-91A6DFF5AC1BQ36723763-4A7110BA-43F4-4D57-AD26-9ECCB3D00AECQ37236015-C65CF724-4E3C-420E-ACBF-C8CD90FE6381Q37236243-8BF9B9C3-585B-437D-A232-2563FC8D7A78Q37581947-9C579624-7E7C-49FF-8F72-BAC87C7277DAQ38397651-2D5BD7F6-D0A3-4A8B-9415-1428F0F18F90Q38887987-EB86B4B4-7D22-4134-9FD4-D19ABDA936C4Q39144762-C5B6FA9B-63EB-474F-9AA1-1971099D902A
P2860
DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma
description
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2012)
@en
vedecký článok (publikovaný 2012)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd in 2012)
@nl
наукова стаття, опублікована у 2012
@uk
مقالة علمية (نشرت عام 2012)
@ar
name
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@ast
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@en
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@nl
type
label
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@ast
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@en
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@nl
prefLabel
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@ast
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@en
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@nl
P2093
P2860
P1433
P1476
DW-MRI as a biomarker to compa ...... or gemcitabine in glioblastoma
@en
P2093
Alnawaz Rehemtulla
Brian D Ross
Craig J Galbán
Eric C Holland
Judith S Leopold
Kevin A Heist
Stefanie Galbán
Terence M Williams
Theodore S Lawrence
P2860
P304
P356
10.1371/JOURNAL.PONE.0035857
P407
P577
2012-01-01T00:00:00Z